Grantham, Mayo, Van Otterloo & Co (GMO)
CRL icon

Grantham, Mayo, Van Otterloo & Co (GMO)’s Charles River Laboratories CRL Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-4,800
Closed -$697K – 719
2019
Q1 		$697K Buy
4,800
+300
+7% +$39.4K 0.01% 533
2018
Q4 		$509K Buy
4,500
+1,700
+61% +$213K ﹤0.01% 436
2018
Q3 		$377K Buy
+2,800
New +$346K ﹤0.01% 464
2018
Q1 		– Sell
-3,500
Closed -$383K – 580
2017
Q4 		$383K Buy
3,500
+300
+9% +$32.6K ﹤0.01% 481
2017
Q3 		$346K Hold
3,200
– – ﹤0.01% 450
2017
Q2 		$324K Buy
3,200
+700
+28% +$64.4K ﹤0.01% 454
2017
Q1 		$225K Buy
+2,500
New +$212K ﹤0.01% 517

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return